Overview

Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants

Status:
Completed
Trial end date:
2017-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine if adding paracetamol to ibuprofen is superior to ibuprofen only for treatment of patent ductus arteriosus (PDA) in preterm infants.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Rambam Health Care Campus
Treatments:
Acetaminophen
Ibuprofen
Criteria
Inclusion Criteria:

- Preterm infants born at 24-37 gestational age

- diagnosis of Hemodynamically significant patent ductus arteriosus

- Medical staff decided to treat with Ibuprofen

- Parents have signed informed consent

Exclusion Criteria:

- Contraindication for ibuprofen

- Alanine transaminase /Aspartate transaminase≥ 200 U/L

- Significant congenital heart disease